Back

Copper chelation in hypertrophic cardiomyopathy; open-label pilot study assessing the effects of trientine on lv mass, myocardial fibrosis, performance and metabolism.

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Cardiomyopathy Cardiomyopathies ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Anna Reid

Manchester University NHS Foundation Trust, Manchester (United Kingdom of Great Britain & Northern Ireland)

26 More presentations in this session

Presentation thumbnail
Associate Professor T. Kara (Rochester, US)
Abstract
Presentation thumbnail
Doctor S. Zhai (Beijing, CN)
Abstract Slides
Presentation thumbnail
Doctor G. Galati (Milan, IT)
Presentation thumbnail
Doctor A. Axelsson Raja (Copenhagen, DK)
Abstract
Presentation thumbnail
Doctor G. Todiere (Pisa, IT)
Abstract

Access the full session

Session thumbnail
Poster session 5 - Cardiomyopathy

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources